Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. حسب Denis Mustafov (19137870)

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. حسب Denis Mustafov (19137870)

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. حسب Peiqi Yin (6533747)

Deficiency of <i>Irg1</i> decreased lung neutrophils in mice during <i>M</i>. <i>pneumoniae</i> infection. حسب Cui Wang (141700)

The nsP4-Q192L and C483Y mutations decrease the 4′-FlU sensitivity of both replication and transcription. حسب Peiqi Yin (6533747)

Splenocytes from Tcj2 mRNA LNP—Immunized mice decrease <i>T</i>. <i>cruzi</i> infection <i>in vitro</i>. حسب Leroy Versteeg (4248760)

<i>C</i>. <i>auris</i> induces IL-1Ra in macrophages to decrease the neutrophil function in the skin. حسب Abishek Balakumar (20189865)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 ^a indicates ≥1.50 SD (17.9) from the mean (32.9... حسب Luke R. Cavanah (19022435)

Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 ^a indicates ≥1.50 SD (20.2) from the mean (36.... حسب Luke R. Cavanah (19022435)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 ^a indicates ≥1.50 SD (18.0) from the mean (33.1... حسب Luke R. Cavanah (19022435)

Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 ^a indicates ≥1.50 SD (16.8) from the mean (31.0... حسب Luke R. Cavanah (19022435)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 ^a indicates ≥1.50 SD (16.0) from the mean (29.9... حسب Luke R. Cavanah (19022435)

Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 ^a indicates ≥1.50 SD (19.2) from the mean (34.... حسب Luke R. Cavanah (19022435)

Scaling of overall health burden with yearly expenditure growth. حسب Margherita Molaro (17803989)

Increased or reduced ATGL-1 activity does not significantly change <i>N. parisii</i> growth. حسب Hala Tamim El Jarkass (16625309)

<i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants. حسب Hala Tamim El Jarkass (16625309)

Evolution of health burden and life expectancy under different expenditure scenarios. حسب Margherita Molaro (17803989)

A T-test mean comparison of pre and post COVID-19 differences for selected variables. حسب Beshir Bedru Nasir (8218863)

Intraperitoneal injection protocol for inhibitors (A), inhibitors DAS and Y27632 reduced intestinal permeability (B) and intestinal adult worm burden (C) of infected mice. حسب Wen Wen Zheng (17721404)

A summary of calibration standards (n = 3). حسب Ewa Paszkowska (21246702)

"…<div><p>Purpose</p><p>Statins are the most commonly used drugs worldwide. Besides a significant decrease in cardiovascular diseases (CVDs) risk, the use of statins is also connected with a broad beneficial pleiotropic effect. …"